A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/21/2016 |
| Start Date: | November 2007 |
| End Date: | November 2010 |
Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies
The objective of this randomized trial is to evaluate the effect of providing full
prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins,
beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers
to patients recently discharged from hospital after acute myocardial infarction.
prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins,
beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers
to patients recently discharged from hospital after acute myocardial infarction.
Inclusion Criteria:
- discharged alive from hospital after acute MI
- receive health services and prescription drug benefits through Aetna, Inc.
Exclusion Criteria:
- enrollment in a Health Savings Account (HSA) plan
- age ≥ 65 years of age at the time of hospital discharge
- plan sponsor has opted out of participating in the study
- receive only medical services or pharmacy coverage but not both through Aetna
We found this trial at
1
site
Click here to add this to my saved trials
